Screener
Inspire Medical Systems INSP Q2 2026 earnings
Reported August 3, 2026 · After market close
Revenue$200.6MBeat by $5.9M
EPS$0.14Beat by $0.38
Revenue estimate$194.7M
EPS estimate-$0.24
“Our second quarter results reflect the increased discipline and focus we are bringing to the business as we continue to support customers through the evolving coding and reimbursement environment and invest in the long-term adoption of Inspire therapy. We are also announcing a strategic growth plan designed to generate approximately $30 million of annualized growth investment capacity, which we intend to redeploy into targeted growth initiatives. We believe these actions will strengthen our operating foundation, sharpen our focus on the highest-return opportunities, and position Inspire for sustainable growth and long-term value creation.”
Next report
Nov 2, 2026 (in a month)Revenue estimate$204.2M
EPS estimate$0.11
Valuation & ratios
Valuation
as of 09/16/26Versus estimates
Revenue
Diluted EPS
FAQ
- When did Inspire Medical Systems report Q2 2026 earnings?
- Inspire Medical Systems (INSP) reported Q2 2026 earnings on August 3, 2026 after market close.
- What were Inspire Medical Systems's Q2 2026 revenue and EPS?
- Inspire Medical Systems reported revenue of $200.6M and eps of $0.14 for Q2 2026.
- Did Inspire Medical Systems beat estimates in Q2 2026?
- Revenue beat the consensus estimate of $194.7M by $5.9M. EPS beat the consensus estimate of $-0.24 by $0.38.
- How did Inspire Medical Systems's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 7.6% from $217.1M a year earlier and eps declined 68.9% from $0.45.
- Where can I find Inspire Medical Systems's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001609550-26-000045) and the 10-Q periodic report (0001609550-26-000047) directly on SEC EDGAR. The filing index links above go to sec.gov.
